Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05235165 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 232 to 233v41
  2. Study sites revised (232)v40 See this version in full on ClinicalTrials.gov ↗
  3. Enrollment target: 250 to 62 Secondary endpoints: 4 to 2 · Study description shortened, about 54 words · Site details revised at 5 of 232 sitesv39 Show 3 more changesShow less
    • Secondary endpoints: 4 to 2
    • Study description shortened, about 54 words
    • Site details revised at 5 of 232 sites

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites revised (232)v38 See this version in full on ClinicalTrials.gov ↗
  5. Study sites revised (232)v37 See this version in full on ClinicalTrials.gov ↗
Show 35 earlier versionsHide 35 earlier versions
  1. Study sites revised (232)v36 See this version in full on ClinicalTrials.gov ↗
  2. Site contacts updated at 2 of 232 sitesv35
  3. Study sites revised (232)v34 See this version in full on ClinicalTrials.gov ↗
  4. Study sites: 231 to 232v33
  5. Study sites: 230 to 231v32
  6. Site details revised at 21 of 230 sitesv31
  7. Site details revised at 4 of 230 sitesv30
  8. Study sites: 229 to 230v29
  9. Study sites revised (229)v28 See this version in full on ClinicalTrials.gov ↗
  10. Site details revised at 2 of 229 sitesv27
  11. Study sites: 226 to 229v26
  12. Study sites: 224 to 226v25
  13. Study sites: 221 to 224v24
  14. Site details revised at 4 of 221 sitesv23
  15. Eligibility criteria expanded, about 51 words Study sites revised (221)v22 Show 1 more changeShow less
    • Study sites revised (221)

    See this version in full on ClinicalTrials.gov ↗

  16. Study sites: 220 to 221v21
  17. Start date: Feb 15, 2022 to Apr 1, 2022 Study sites: 219 to 220v20 Show 1 more changeShow less
    • Study sites: 219 to 220
  18. Study sites: 218 to 219v19
  19. Study sites: 213 to 218v18
  20. Study sites: 212 to 213v17
  21. Primary and study completion dates: Dec 15, 2027 to Mar 31, 2031 Study sites: 208 to 212v16 Show 1 more changeShow less
    • Study sites: 208 to 212
  22. Study sites: 207 to 208v15
  23. Study sites: 153 to 207 Interventions: Questionnaire Administration (Other), Thoracoscopy (Procedure), Thoracotomy (Procedure) to Biospecimen Collection (Procedure), Computed Tomography (Procedure), Questionnaire Administration (Other), Thoracoscopy (Procedure)… · Study description expanded, about 23 words · Eligibility criteria expanded, about 2 wordsv14 Show 3 more changesShow less
    • Interventions: Questionnaire Administration (Other), Thoracoscopy (Procedure), Thoracotomy (Procedure) to Biospecimen Collection (Procedure), Computed Tomography (Procedure), Questionnaire Administration (Other), Thoracoscopy (Procedure)…
    • Study description expanded, about 23 words
    • Eligibility criteria expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  24. Study sites: 128 to 153v13
  25. Study sites: 102 to 128v12
  26. Study sites: 89 to 102v11
  27. Study sites: 75 to 89v10
  28. Study sites: 74 to 75v9
  29. Study sites: 67 to 74v8
  30. Study sites: 57 to 67v7
  31. Re-verified, no change to tracked fieldsv6
  32. Study sites: 53 to 57 Secondary endpoints: details revised at 2 of 4 entriesv5 Show 1 more changeShow less
    • Secondary endpoints: details revised at 2 of 4 entries
  33. Study sites: 49 to 53v4
  34. Study sites: 7 to 49 Secondary endpoints: details revised at 2 of 4 entriesv3 Show 1 more changeShow less
    • Secondary endpoints: details revised at 2 of 4 entries
  35. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 7v2 Show 1 more changeShow less
    • Study sites: 0 to 7
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Trial Details
NCT Number NCT05235165
Lead Sponsor Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Conditions Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma, Osteosarcoma
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov